New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2014
08:16 EDTAXNAoxing Pharmaceutical receives notice of extension from NYSE
Aoxing Pharmaceutical announced on October 30, 2013 that it had received notice from NYSE MKT that, based upon the financial statements contained in Aoxing Pharma's Annual Report on Form 10-K for the year ended June 30, 2013, Aoxing Pharma is not in compliance with Section 1003(a)(iii) of the NYSE MKT Company Guide since it reported stockholders' equity of less than $6M at June 30, 2013 and has incurred losses from continuing operations and/or net losses in its five most recent fiscal years then ended. On December 4, 2013, Aoxing Pharma announced that it had received additional notice from NYSE MKT that, based upon the financial statements contained in Aoxing Pharma's Quarterly Report on Form 10-Q for the period ended September 30, 2013, it is also not in compliance with Section 1003(a)(ii) of the Company Guide since it reported stockholders' equity of less than $4M at September 30, 2013 and has incurred losses from continuing operations and/or net losses in three of its four most recent fiscal years ended June 30, 2013.
News For AXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 1, 2016
08:34 EDTAXNAoxing Pharmaceutical names James Chen as CFO, effective today
Aoxing Pharmaceutical Company (AXN) announced that Dr. James Chen has joined the company as CFO, effective as of February 1, 2016. Guoan Zhang, who had served as Interim CFO, will continue to serve as Vice President - Finance and Controller for the company. Before joining Aoxing Parma, Dr. Chen was the CFO of Origin Agritech (SEED).

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use